|
|
 Previous Article | Table of Contents | Next Article 
Mechanism of tissue factor activation on HL-60 cells
RR Bach and CF Moldow
Veterans Affairs Medical Center, Research Service (151), Minneapolis, MN
55417, USA.
Tissue factor (TF) procoagulant activity (PCA) on the surface of intact
HL-60 cells is encrypted. This latent TF PCA was activated by exposing the
cells to ionomycin, a calcium ionophore. Within seconds an increase in TF
PCA of greater than 100-fold was observed. The ionomycin effect was blocked
by pretreating the cells with calmidazolium, a calmodulin inhibitor.
Changes in TF structure and function, coincident with the ionophore-induced
increase in TF PCA, were identified. TF-factor VIIa complexes formed on
both untreated and ionophore-treated cells, but pseudosubstrate inhibitors
only bound to TF-factor VIIa on the ionophore-treated cells. TF PCA was
inhibited by reacting cells with
sulfosuccinimidyl-6-(biotinamido)hexanoate, and the rate of this reaction
increased twofold after cells were exposed to ionomycin. When proteins on
the surface of untreated cells, expressing minimal TF PCA, were
cross-linked with 3-3'-dithiobis(sulfosuccinimidylpropionate), cross-linked
TF dimers were produced. TF cross-linking was prevented by first treating
the cells with ionomycin. These results suggest a mechanism for the
ionomycin-induced increase in TF PCA. TF activation appears to be a
calmodulin-dependent process, which exposes an essential macromolecular
substrate binding site on TF, possibly as the result of a change in TF
quaternary structure.
Volume 89,
Issue 9,
pp. 3270-3276,
05/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. R. Bach and D. Monroe
What Is Wrong With the Allosteric Disulfide Bond Hypothesis?
Arterioscler Thromb Vasc Biol,
December 1, 2009;
29(12):
1997 - 1998.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. P. H. Liang and P. J. Hogg
Critical importance of the cell system when studying tissue factor de-encryption
Blood,
August 1, 2008;
112(3):
912 - 913.
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. R. Pendurthi, S. Ghosh, S. K. Mandal, and L. V. M. Rao
Tissue factor activation: is disulfide bond switching a regulatory mechanism?
Blood,
December 1, 2007;
110(12):
3900 - 3908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Boden, V. Vaidyula, C. Homko, M. Mozzoli, and A. K. Rao
Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1333 - E1339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Camino-Lopez, V. Llorente-Cortes, J. Sendra, and L. Badimon
Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells
Cardiovasc Res,
January 1, 2007;
73(1):
208 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. R. Vaidyula, A. K. Rao, M. Mozzoli, C. Homko, P. Cheung, and G. Boden
Effects of Hyperglycemia and Hyperinsulinemia on Circulating Tissue Factor Procoagulant Activity and Platelet CD40 Ligand
Diabetes,
January 1, 2006;
55(1):
202 - 208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Pozza and R. C. Austin
Getting a GRP on Tissue Factor Activation
Arterioscler Thromb Vasc Biol,
August 1, 2005;
25(8):
1529 - 1531.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Mandal, A. Iakhiaev, U. R. Pendurthi, and L. V. M. Rao
Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol
Blood,
January 1, 2005;
105(1):
153 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Aras, A. Shet, R. R. Bach, J. L. Hysjulien, A. Slungaard, R. P. Hebbel, G. Escolar, B. Jilma, and N. S. Key
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia
Blood,
June 15, 2004;
103(12):
4545 - 4553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Watson, A. K. C. Chan, L. R. Berry, J. Li, S. K. Sood, J. G. Dickhout, L. Xu, G. H. Werstuck, L. Bajzar, H. J. Klamut, et al.
Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity
J. Biol. Chem.,
May 2, 2003;
278(19):
17438 - 17447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Shebuski and K. S. Kilgore
Role of Inflammatory Mediators in Thrombogenesis
J. Pharmacol. Exp. Ther.,
March 1, 2002;
300(3):
729 - 735.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. L. Nelsestuen, M. Stone, M. B. Martinez, S. B. Harvey, D. Foster, and W. Kisiel
Elevated Function of Blood Clotting Factor VIIa Mutants That Have Enhanced Affinity for Membranes. BEHAVIOR IN A DIFFUSION-LIMITED REACTION
J. Biol. Chem.,
October 19, 2001;
276(43):
39825 - 39831.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. de Jonge, P. E. P. Dekkers, A. A. Creasey, C. E. Hack, S. K. Paulson, A. Karim, J. Kesecioglu, M. Levi, S. J. H. van Deventer, and T. van der Poll
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Blood,
February 15, 2000;
95(4):
1124 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Iakhiaev, U. R. Pendurthi, J. Voigt, M. Ezban, and L. V. M. Rao
Catabolism of Factor VIIa Bound to Tissue Factor in Fibroblasts in the Presence and Absence of Tissue Factor Pathway Inhibitor
J. Biol. Chem.,
December 24, 1999;
274(52):
36995 - 37003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. B. Hansen, B. van Deurs, L. C. Petersen, and L. V. M. Rao
Discordant Expression of Tissue Factor and Its Activity in Polarized Epithelial Cells. Asymmetry in Anionic Phospholipid Availability as a Possible Explanation
Blood,
September 1, 1999;
94(5):
1657 - 1664.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Penn, C. V. Patel, M.-Z. Cui, P. E. DiCorleto, and G. M. Chisolm
LDL Increases Inactive Tissue Factor on Vascular Smooth Muscle Cell Surfaces : Hydrogen Peroxide Activates Latent Cell Surface Tissue Factor
Circulation,
April 6, 1999;
99(13):
1753 - 1759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. S. Key, A. Slungaard, L. Dandelet, S. C. Nelson, C. Moertel, L. A. Styles, F. A. Kuypers, and R. R. Bach
Whole Blood Tissue Factor Procoagulant Activity Is Elevated in Patients With Sickle Cell Disease
Blood,
June 1, 1998;
91(11):
4216 - 4223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Schecter, B. J. Rollins, Y. J. Zhang, I. F. Charo, J. T. Fallon, M. Rossikhina, P. L. A. Giesen, Y. Nemerson, and M. B. Taubman
Tissue Factor Is Induced by Monocyte Chemoattractant Protein-1 in Human Aortic Smooth Muscle and THP-1 Cells
J. Biol. Chem.,
November 7, 1997;
272(45):
28568 - 28573.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
